Mechanistically, the inhibition of CERS1 disrupts mitochondrial quality control in CDDP‐resistant osteosarcoma cells through the inhibition of mitophagy, leading to the dissipation of mitochondrial membrane potential and unfavourable alterations in mitochondrial dynamics. The gene discussed is CERS1; the disease is osteosarcoma.